Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-20

Clinical Trial Update: Cyclosporine For The Treatment Of COVID-19(+) [Phase 2]

View source ↗

Summary

Clinical trial update on cyclosporine for COVID-19 positive patients in Phase 2, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Bryan Burt, MD | Conditions: SARS (Disease) | Phase 2 | Status: COMPLETED | Results posted: 2023-07-20